MedTrace Logo

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study

NCT02353351 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 602

Last updated 2019-02-04

No results posted yet for this study

Summary

Prospective, multicenter, case-cohort study.To identify potential risk factors associated with the occurrence of erosion due to implantation of the AMPLATZER™ Septal Occluder (ASO.)

Conditions

  • Atrial Septal Defect Secundum

Interventions

DEVICE

atrial septal occluder

Single arm atrial septal defect closure with the AMPLATZER Septal Occluder

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Ashish Oza · Abbott Medical Devices

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-19
Primary Completion
2017-02-24
Completion
2017-02-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353351 on ClinicalTrials.gov